Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.
Severe falciparum malaria is one of the most lethal parasitic infections in the world and is responsible for more than one million deaths in African children per year. Changes to management over the last 40 years have not improved survival. A reduction in the mortality and morbidity may only come about by a better understanding of the pathophysiological processes that are responsible for severe disease and that determine the outcome before antimalarials have had time to work. This review discusses potential adjunctive therapies for severe malaria that are under development following such detailed clinical and pathophysiological studies.
Neurosciences Unit, Institute of Child Health, Wolfson Centre, London, UK.
C R
CR
Newton
S
S
Krishna
D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002648:Child; D003937:Diagnosis, Differential; D006801:Humans; D016779:Malaria, Cerebral / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology*; D009017:Morbidity; D010963:Plasmodium falciparum / Q000472:pathogenicity*; D015996:Survival Rate
D000962:Antimalarials